John will be responsible at executive level for Contract Manufacturing, Clinical Trial Supply and Project Management activities at Penn. John, who has more than 20 years experience working in the pharmaceutical industry, joins the company from Marix Drug Development Ltd, where he held the position of Commercial Director. Previously he worked at UCB Pharma Ltd in the UK and Asia as General Manager and also at Wellcome Plc, where he started his career after graduating from the University of North Wales with a BSc in Biochemistry in 1982. Commenting on his appointment, John said: "I am pleased to be joining one of the UK’s leading pharmaceutical services companies. The market for outsourced development services in the pharma sector is one that has gone from strength to strength in recent years and I look forward to working with the successful team at Penn to help develop and grow the business in response to current market conditions." Craig Rennie, Chief Executive at Penn Pharmaceuticals added: "I am delighted to welcome John to the company, at what is a very exciting time for us. I have known John personally for 20 years and I know that his professional experience and expertise as well as his energy, enthusiasm and drive will benefit Penn greatly as he settles into his new role." Penn Pharmaceutical Services Ltd is a leading provider of outsourced pharmaceutical development services to the international healthcare industry. The company’s core business expertise includes a fully comprehensive product development service, which consists of formulation and analytical development, clinical trial manufacturing, packaging and supply management and extensive contract manufacturing. Penn also offers CMC Consultancy and Qualified Person (QP) Services.